Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Delta 9 Cannabis Inc. T.DN

Alternate Symbol(s):  DLTNF

Healthcare Cannabis
Delta 9 Cannabis Inc. is a Canada-based vertically integrated cannabis company. The Company operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. It also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. It is focused on producing and selling cannabis oils, extracts, and derivative products.


TSX:DN - Post by User

Delta 9 Cannabis Inc. > Read a balance sheet lately
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Comment by Bullknit101on Dec 01, 2020 11:05pm
82 Views
Post# 32015840

RE:Read a balance sheet lately

RE:Read a balance sheet latelyAnother Canadian cannabinoid biotech you may want to check out is InMed Pharma. They aren't leveraged and revenues are anticipated in FY 2022 (July 2021). They are in a quiet period after their NASDAQ IPO. The period ends around 28 Dec. They have a partnership with Almac and Baymedica. Integrasyn is their golden egg, likely to be the most optimal process on the market for cannabinoid synthesis.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities